Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 75

Last updated on 2024-06-11 History
Report ID 227003
Drug Identification Number 02341697
Brand name GD-DICLOFENAC/MISOPROSTOL 75
Common or Proper name GD-DICLOFENAC/MISOPROSTOL 75
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MISOPROSTOL DICLOFENAC SODIUM
Strength(s) 200MCG 75MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 250's
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-05-24
Actual start date 2024-05-15
Estimated end date 2024-06-21
Actual end date 2024-06-06
Shortage status Resolved
Updated date 2024-06-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-06-11 French Compare
v9 2024-06-11 English Compare
v8 2024-05-16 English Compare
v7 2024-05-15 French Compare
v6 2024-05-15 English Compare
v5 2024-05-14 French Compare
v4 2024-05-14 English Compare
v3 2024-05-14 English Compare
v2 2024-05-03 French Compare
v1 2024-05-03 English Compare

Showing 1 to 10 of 10